Revenue · 2011–2025
Ionis Pharmaceuticals revenue
$944M+33.8% · FY2025
Ionis Pharmaceuticals (IONS) reported $944M in revenue for fiscal 2025, +33.8% year on year.
| Fiscal year | Revenue | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $944M | +33.8% | Open → |
| FY20242024-12-31 | $705M | −10.5% | Open → |
| FY20232023-12-31 | $788M | +34.1% | Open → |
| FY20222022-12-31 | $587M | −27.5% | Open → |
| FY20212021-12-31 | $810M | +11.1% | Open → |
| FY20202020-12-31 | $729M | −35.0% | Open → |
| FY20192019-12-31 | $1.1B | +87.2% | Open → |
| FY20182018-12-31 | $600M | +16.6% | Open → |
| FY20172017-12-31 | $514M | +37.9% | Open → |
| FY20162016-12-31 | $373M | +31.4% | Open → |
| FY20152015-12-31 | $284M | +32.5% | Open → |
| FY20142014-12-31 | $214M | +45.4% | Open → |
| FY20132013-12-31 | $147M | +44.3% | Open → |
| FY20122012-12-31 | $102M | +3.0% | Open → |
| FY20112011-12-31 | $99.1M | — | Open → |
Revenue — Revenue is total net sales for the fiscal year, taken from each company's own annual filing.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +17.5%
Revenue at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Ionis Pharmaceuticals revenue |url=https://companiesranked.com/en/company/ionis-pharmaceuticals/revenue |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Ionis Pharmaceuticals revenue. CompaniesRanked. https://companiesranked.com/en/company/ionis-pharmaceuticals/revenueBibTeX
@misc{companiesranked-en-company-ionis-pharmaceuticals-revenue-2026,
author = {{CompaniesRanked}},
title = {{Ionis Pharmaceuticals revenue}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/ionis-pharmaceuticals/revenue}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0000874015-26-000115 · February 26, 2026
{{cite web |title=Ionis Pharmaceuticals revenue — 10-K (0000874015-26-000115) |url=https://www.sec.gov/Archives/edgar/data/874015/000087401526000115/form10k.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-26}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.